We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Osel Reports Promising Results From Immunotherapy Study as Finch Trial Stalls
Osel Reports Promising Results From Immunotherapy Study as Finch Trial Stalls
Therapies based on the human gut microbiome are in the news with one company, Osel, releasing encouraging phase 1b data and another, Finch, receiving an FDA clinical hold during a phase 3 recruitment.